Brief

On 19/12/2024, the Federal Tax Service (FTS) issued an update regarding The CMD explained the specifics of receiving a tax deduction for the purchase of medicines. The tax deduction can be claimed in the amount of actual expenses on medication purchases, but not exceeding 120,000 rubles per calendar year, starting from 150,000 rubles from January 1, 2024.

Дата публикации: 19.12.2024 10:38

Это архивная публикация – она может содержать устаревшую информацию.

Сотрудники ИФНС России № 17 провели семинар в Центре московского долголетия ВДНХ. Налоговики объяснили особенности получения социального налогового вычета по расходам на приобретение медикаментов. Налогоплательщику предоставляется возможность получения вычета в размере стоимости любых лекарственных препаратов для медицинского применения, назначенных налогоплательщику и членам его семьи, лечащим врачом и приобретаемых налогоплательщиком за счет собственных средств.Вычет можно получить в отношении любого назначенного врачом лекарства. Для получения социального налогового вычета необходимо наличие рецептурного бланка.Данным налоговым вычетом можно воспользоваться в размере фактически произведенных расходов на приобретение медикаментов, но в совокупности не более 120 000 рублей за календарный год. Начиная с расходов с 01.01.2024 – 150 000 рублей.Неиспользованный остаток социального налогового вычета перенести на следующий год нельзя.

Поделиться:

Highlights content goes here...

Purpose:
The purpose of this update is to inform taxpayers about the specifics of obtaining a social tax deduction for expenses related to purchasing medications. The update aims to clarify the rules and limitations surrounding this tax benefit, enabling taxpayers to make informed decisions regarding their tax obligations.

Effects on Industry:

The update’s primary impact will be on individual taxpayers who incur medical expenses, particularly those purchasing prescribed medications. By allowing a tax deduction for these expenditures, the update aims to provide financial relief to those in need. This, in turn, may lead to increased access to healthcare services and improved overall health outcomes.

Furthermore, the update’s provisions regarding the maximum allowable tax deduction (RUB 120,000 per calendar year) may influence taxpayers’ decisions when it comes to seeking medical care and managing their healthcare expenses. Healthcare providers and insurance companies might also be affected indirectly, as they will need to consider the implications of this tax benefit on patient behavior and demand for services.

Relevant Stakeholders:

The following stakeholders are directly or indirectly impacted by this update:

  • Individual taxpayers, particularly those with chronic medical conditions or significant healthcare expenses
  • Healthcare providers and pharmaceutical companies, which may experience changes in demand for their services and products
  • Insurance companies, which will need to consider the implications of this tax benefit on patient behavior and demand for health insurance coverage
  • Tax authorities and government agencies responsible for administering the tax code and enforcing compliance with its provisions

Next Steps:

To comply with or respond to this update, taxpayers should:

  1. Review their medical expenses and determine whether they qualify for a social tax deduction
  2. Obtain a prescription from a licensed healthcare provider to document their medical needs
  3. Keep records of their medication purchases and associated costs to support their tax claim
  4. Consult with a tax professional or accountant if necessary, to ensure compliance with the relevant tax laws and regulations

Any Other Relevant Information:

In addition to the above information, it is worth noting that:

  • The social tax deduction for medical expenses is subject to change based on amendments to the tax code or regulatory updates
  • Taxpayers should stay informed about any changes to the tax law or relevant regulations affecting their eligibility for this benefit
  • This update may have broader implications for healthcare policy and access, particularly if it influences patient behavior and demand for health services

Federal Tax Service (FTS)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies